Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? Yes
Write-up: This case was reported by a other health professional and described the occurrence of intussusception in a 8-month-old male patient who received ROTARIX (batch number A41CB393A, expiry date 5th October 2016). Concomitant products included ROTARIX, PEDIARIX, PREVENAR and HIB. On 4th June 2014 11:30, the patient received the 2nd dose of ROTARIX (oral). On 1st October 2014, 119 days after receiving ROTARIX, the patient experienced intussusception (serious criteria hospitalization, GSK medically significant, life threatening and clinically significant/intervention required), bloody stool (serious criteria GSK medically significant) and absent bowel sounds. On an unknown date, the outcome of the intussusception, bloody stool and absent bowel sounds were not recovered/not resolved. It was unknown if the reporter considered the intussusception, bloody stool and absent bowel sounds to be related to ROTARIX. Additional information was provided. The patient had no known allergy, no relevant medical history and no reaction to previous vaccinations. The patient had no current medication. At the time of reporting, the patient was hospitalized, the events were worsened and the patient was possibly having surgery.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166